Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Therapy Name | KK-LC-1 TCR-T cells |
Synonyms | |
Therapy Description |
KK-LC-1 TCR-T cells are T-lymphocytes engineered to express a T-cell receptor (TCR) targeting KK-LC-1 (CT83), which may inhibit growth KK-LC-1 (CT83)-expressing tumors (PMID: 31455429). |
Drug Name | Trade Name | Synonyms | Drug Classes | Drug Description |
---|---|---|---|---|
KK-LC-1 TCR-T cells | Autologous Anti-KK-LC-1 TCR-expressing T-cells | KK-LC-1 TCR-T cells are T-lymphocytes engineered to express a T-cell receptor (TCR) targeting KK-LC-1 (CT83), which may inhibit growth KK-LC-1 (CT83)-expressing tumors (PMID: 31455429). |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|
Clinical Trial | Phase | Therapies | Title | Recruitment Status | Covered Countries | Other Countries |
---|